Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TORII PHARMA, Jan-Mar (1Q) Ordinary Profit Increases by 59%
4551 TORII PHARMACEUTICAL CO., LTD. 【J-GAAP】
Earnings ReportTORII PHARMACEUTICAL CO., LTD. <4551> [TSE Prime] announced its financial results after the market closed on April 25th (15:30). The ordinary profit (non-consolidated) for the first quarter of the fiscal year ending December 2025 (January to March) expanded 1.85 billion yen, an increase 59.4% compared to the same period last year. The progress rate toward the full-year plan of 4.5 billion yen was 41.3%, also surpassing the five-year average of 19.8%.
In the most recent three-month period, from January to March (1Q), the operating profit margin rose from 10.3% in the same period last year to 11.6%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2023 | 11,811 | -437 | -404 | -288 | -10.3 | ー | Apr 28, 2023 | J-GAAP |
Jan - Mar, 2024 | 13,451 | 1,383 | 1,166 | 878 | 31.3 | 39.1 | Apr 26, 2024 | J-GAAP |
Jan - Mar, 2025 | 14,683 | 1,704 | 1,859 | 1,391 | 49.5 | ー | Apr 25, 2025 | J-GAAP |
YoY | +9.2% | +23.2% | +59.4% | +58.4% | +58.3% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 28,309 | 3,141 | 2,985 | 2,221 | 79.0 | 60 | Jul 31, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 60 | Feb 7, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 54,638 | 5,035 | 5,307 | 4,119 | 146.6 | 120 | Feb 9, 2024 | J-GAAP |
Dec, 2024 | 60,426 | 6,798 | 6,926 | 5,042 | 179.4 | 120 | Feb 7, 2025 | J-GAAP |
Dec, 2025 Guidance | 64,700 | 4,100 | 4,500 | 3,400 | 120.9 | 120 | Feb 7, 2025 | J-GAAP |
YoY | +7.1% | -39.7% | -35.0% | -32.6% | -32.6% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 13,451 | 1,383 | 1,166 | 878 | 31.3 | 10.3 | Apr 26, 2024 | J-GAAP |
Apr - Jun, 2024 | 14,858 | 1,758 | 1,819 | 1,343 | 47.8 | 11.8 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 15,024 | 1,520 | 1,701 | 1,304 | 46.4 | 10.1 | Oct 31, 2024 | J-GAAP |
Oct - Dec, 2024 | 17,093 | 2,137 | 2,240 | 1,517 | 54.0 | 12.5 | Feb 7, 2025 | J-GAAP |
Jan - Mar, 2025 | 14,683 | 1,704 | 1,859 | 1,391 | 49.5 | 11.6 | Apr 25, 2025 | J-GAAP |
YoY | +9.2% | +23.2% | +59.4% | +58.4% | +58.3% |
Related Articles
ADVANTEST, 11% Increase in Net Income, Update Record High for Second Consecutive Term
Astellas Pharma, Last Fiscal Year's Net Income Unexpectedly Increases, 2.6 times Increase in Net Income for The Current Fiscal Year, Dividend Raised by 4 yen
TORICO, Last Fiscal Year Net Income Loss Widened in Downward Revision
ANRITSU, 19% Increase in Net Income for The Current Fiscal Year
ZENITAKA, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 2% Increase, Dividend Revised Upward by 20 yen
SEMITEC, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 5% Increase
TOWNNEWS-SHA, Jul-Mar (Cumulative 3Q) Ordinary Profit Decreases by 15%, Jan-Mar Ordinary Profit Decreases by 16%
INTELLEX, The Current Fiscal Year Ordinary Profit Revised Upward by 18%, Dividend Revised Upward by 12 yen
KINDEN, 8% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Increased Previous Year's Dividend by 8 yen, This Fiscal Year to Increase Dividend by 10 yen
MITSUBISHI PENCIL, Jan-Mar (1Q) Ordinary Profit Decreases by 33%